Completed
An Open-Label, Proof-of-Concept Study of Ixekizumab in the Treatment of Pyoderma Gangrenosum
NCT03137160
- Conditions
- Pyoderma, Pyoderma Gangrenosum, Skin Diseases, +3 more
- Locations
-
- The Ohio State University Dermatology Gahanna, Ohio, United States